论文部分内容阅读
在对多篇已发表的比较GnRH激动剂和其他治疗方案在前列腺癌患者中安全性的研究论文进行回顾和综述的基础上,FDA于2010年10月20日发出警告,称促黄体生成素释放激素(GnRH)激动剂类前列腺癌治疗药物可导致某些心血管事件(如心脏
Based on a review and review of several published research articles comparing the safety of GnRH agonists and other treatment regimens in patients with prostate cancer, the FDA warned on October 20, 2010 that luteinizing hormone release Hormone (GnRH) Agonists Prostate cancer drugs can cause certain cardiovascular events (such as heart